CWF19L2 Inhibitors
CWF19L2 inhibitors are a diverse group of chemical compounds that indirectly disrupt the functional activity of CWF19L2 by targeting cellular structures, enzymes, and signaling pathways integral to its operation
For instance, the disruption of actin polymerization by Latrunculin A affects the actin cytoskeleton, which in turn could interfere with CWF19L2's role in chromosome organization and segregation. Similarly, Nocodazole's inhibition of microtubule polymerization can impede cell division processes where CWF19L2 is required, thus indirectly inhibiting its function in mitotic chromosome alignment and segregation.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to the accumulation of proteins destined for degradation. If CWF19L2 is regulated by proteasomal degradation, bortezomib could indirectly inhibit its function by altering protein turnover mechanisms that control CWF19L2 levels. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor and thereby interferes with the repair of single-strand DNA breaks. If CWF19L2 is involved in the pathway for repairing such breaks, inhibition of PARP by olaparib could lead to an accumulation of repair substrates, indirectly inhibiting CWF19L2's function. | ||||||